NASDAQ:CERN - Cerner Stock Price, Price Target & More

$57.94 -0.62 (-1.06 %)
(As of 04/24/2018 04:00 PM ET)
Previous Close$57.94
Today's Range$57.40 - $59.00
52-Week Range$55.29 - $73.86
Volume2.37 million shs
Average Volume2.73 million shs
Market Capitalization$19.32 billion
P/E Ratio26.34
Dividend YieldN/A

About Cerner (NASDAQ:CERN)

Cerner logoCerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform that enables organizations to aggregate, transform, and reconcile data across the continuum of care, as well as EHR agnostic platform, CareAware, that facilitates connectivity of health care devices to EHRs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental, connectivity, population health, and care coordination solutions; and various complementary services, including support, hosting, managed, implementation, and strategic consulting services. Further, it provides various services, such as implementation and training, remote hosting, operational management, revenue cycle, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third party administrator services for employer-based health plans; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri.

Receive CERN News and Ratings via Email

Sign-up to receive the latest news and ratings for CERN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryHealth Care Technology


Debt-to-Equity Ratio0.11%
Current Ratio3.01%
Quick Ratio2.99%


Trailing P/E Ratio26.34
Forward P/E Ratio23.94
P/E Growth1.69

Sales & Book Value

Annual Sales$5.14 billion
Price / Sales3.74
Cash Flow$3.9631 per share
Price / Cash14.62
Book Value$14.40 per share
Price / Book4.02


EPS (Most Recent Fiscal Year)$2.20
Net Income$866.97 million
Net Margins16.86%
Return on Equity16.82%
Return on Assets12.20%


Outstanding Shares331,740,000

How to Become a New Pot Stock Millionaire

Cerner (NASDAQ:CERN) Frequently Asked Questions

What is Cerner's stock symbol?

Cerner trades on the NASDAQ under the ticker symbol "CERN."

How will Cerner's stock buyback program work?

Cerner declared that its Board of Directors has authorized a share buyback program on Sunday, June 4th 2017, which allows the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase up to 2.3% of its shares through open market purchases. Shares buyback programs are often an indication that the company's board of directors believes its stock is undervalued.

How were Cerner's earnings last quarter?

Cerner (NASDAQ:CERN) announced its quarterly earnings data on Tuesday, February, 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.61 by $0.03. The company earned $1.31 billion during the quarter, compared to analysts' expectations of $1.33 billion. Cerner had a return on equity of 16.82% and a net margin of 16.86%. The company's quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.61 earnings per share. View Cerner's Earnings History.

When is Cerner's next earnings date?

Cerner is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Cerner.

What guidance has Cerner issued on next quarter's earnings?

Cerner updated its FY18 earnings guidance on Tuesday, February, 6th. The company provided earnings per share guidance of $2.57-2.73 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.67. The company issued revenue guidance of $5.45-5.65 billion, compared to the consensus revenue estimate of $5.57 billion.Cerner also updated its Q1 guidance to $0.57-0.59 EPS.

What price target have analysts set for CERN?

21 brokers have issued twelve-month price targets for Cerner's stock. Their predictions range from $2.82 to $80.00. On average, they expect Cerner's share price to reach $67.2353 in the next twelve months. View Analyst Ratings for Cerner.

What are Wall Street analysts saying about Cerner stock?

Here are some recent quotes from research analysts about Cerner stock:
  • 1. Cantor Fitzgerald analysts commented, "Various news outlets are suggesting that President Trump will soon replace VA Secretary David Shulkin." (3/14/2018)
  • 2. According to Zacks Investment Research, "Cerner has had an unfavorable run on the bourses over the last year. However, the company witnessed record bookings in the quarter and also a strong cash flow. We believe that the company has growth opportunities in the revenue cycle management (RCM), Population Health and ambulatory markets based on its product strength and enviable track record of adding new clients. Solid growth in the HealtheIntent platform also holds promise. The company performed impressively in the small hospital markets lately. On the flipside, lower margins on technology resale, resulting from higher mix of device resale is a concern. Additionally, Cerner has been facing macroeconomic challenges along with cutthroat competition in niche space. Expensive valuation and surging operating expenses also add to the woes." (2/8/2018)
  • 3. Canaccord Genuity analysts commented, "We reiterate our BUY rating and raise our PT to $73. Not without noise on 4Q’17 and updated guidance, CERN continues to perform in new business wins. Bookings performance was stellar, up 62% y/y on large Works wins with solid growth across many product areas. The delayed Veterans Administration signing and some pre-revenue project investment will likely pressure margins near-term, but will be more than offset on the bottom-line from the tax reform benefit. We normally would be more critical on near-term margin compression; however, given bookings strength and benefits from tax reform, we recommend investors continue to own shares and add to positions. Key positive: Bookings grew 62% to $2.3B, outperforming us and cons. both at $1.8B. 1Q’18 bookings guidance straddled our estimate and con." (2/7/2018)

Who are some of Cerner's key competitors?

Who are Cerner's key executives?

Cerner's management team includes the folowing people:
  • Mr. Zane M. Burke, Pres (Age 52)
  • Mr. Marc G. Naughton, Exec. VP & CFO (Age 63)
  • Mr. Michael R. Nill, Exec. VP & COO (Age 53)
  • Mr. Jeffrey A. Townsend, Exec. VP & Chief of Staff (Age 54)
  • Mr. David Brent Shafer, Chairman & CEO (Age 61)

Has Cerner been receiving favorable news coverage?

Media stories about CERN stock have been trending somewhat positive recently, according to Accern. The research firm scores the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cerner earned a news impact score of 0.12 on Accern's scale. They also gave news stories about the company an impact score of 45.04 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of Cerner?

Shares of CERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cerner's stock price today?

One share of CERN stock can currently be purchased for approximately $57.94.

How big of a company is Cerner?

Cerner has a market capitalization of $19.32 billion and generates $5.14 billion in revenue each year. The company earns $866.97 million in net income (profit) each year or $2.20 on an earnings per share basis. Cerner employs 26,000 workers across the globe.

How can I contact Cerner?

Cerner's mailing address is 2800 ROCKCREEK PKWY W0162, NORTH KANSAS CITY MO, 64117. The company can be reached via phone at 816-221-1024 or via email at [email protected]

MarketBeat Community Rating for Cerner (CERN)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  755 (Vote Outperform)
Underperform Votes:  444 (Vote Underperform)
Total Votes:  1,199
MarketBeat's community ratings are surveys of what our community members think about Cerner and other stocks. Vote "Outperform" if you believe CERN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cerner (NASDAQ:CERN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
21 Wall Street analysts have issued ratings and price targets for Cerner in the last 12 months. Their average twelve-month price target is $67.2353, suggesting that the stock has a possible upside of 16.04%. The high price target for CERN is $80.00 and the low price target for CERN is $2.82. There are currently 10 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldHold
Consensus Rating Score: 2.522.452.352.41
Ratings Breakdown: 0 Sell Rating(s)
10 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
11 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
15 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
13 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $67.2353$67.3039$69.7222$68.4211
Price Target Upside: 16.04% upside8.14% upside0.79% downside4.71% downside

Cerner (NASDAQ:CERN) Consensus Price Target History

Price Target History for Cerner (NASDAQ:CERN)

Cerner (NASDAQ:CERN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/23/2018CitigroupUpgradeNeutral -> BuyLowView Rating Details
4/3/2018Royal Bank of CanadaReiterated RatingBuy$67.00MediumView Rating Details
4/2/2018KeyCorpLower Price TargetOverweight -> Overweight$85.00 -> $76.00MediumView Rating Details
3/31/2018Wells FargoSet Price TargetBuy$75.00MediumView Rating Details
3/29/2018William BlairReiterated RatingBuyLowView Rating Details
3/14/2018Cantor FitzgeraldReiterated RatingBuy$80.00LowView Rating Details
3/13/2018ArgusDowngradeBuy -> Hold$54.49 -> $64.65MediumView Rating Details
3/8/2018Stifel NicolausReiterated RatingHold -> Hold$69.00 -> $71.00MediumView Rating Details
2/27/2018Bank of AmericaInitiated CoverageBuy -> Buy$75.00LowView Rating Details
2/7/2018Robert W. BairdLower Price TargetOutperform -> Outperform$80.00 -> $75.00MediumView Rating Details
2/7/2018Canaccord GenuityReiterated RatingBuyLowView Rating Details
2/7/2018SunTrust BanksLower Price TargetHold$68.00 -> $2.82HighView Rating Details
1/18/2018Evercore ISIInitiated CoverageIn -> In-Line$77.00MediumView Rating Details
11/30/2017Piper JaffrayReiterated RatingBuy$70.00LowView Rating Details
11/25/2017Leerink SwannReiterated RatingHoldMediumView Rating Details
10/29/2017Jefferies GroupReiterated RatingBuyN/AView Rating Details
10/27/2017JPMorgan ChaseDowngradeOverweight -> NeutralN/AView Rating Details
8/10/2017Morgan StanleyUpgradeUnderweight -> Equal Weight$59.00 -> $62.00MediumView Rating Details
6/6/2017UBSReiterated RatingNeutral$64.00 -> $69.00N/AView Rating Details
5/2/2017Hilliard LyonsDowngradeBuy -> Neutral$62.00 -> $68.00MediumView Rating Details
5/1/2017BarclaysReiterated RatingHold$60.00LowView Rating Details
2/10/2017CIBCReiterated RatingOutperform -> Market PerformN/AView Rating Details
2/10/2017OppenheimerReiterated RatingOutperform -> Market PerformN/AView Rating Details
2/10/2017Avondale PartnersDowngradeOutperform -> Market Perform$61.00 -> $45.00N/AView Rating Details
1/31/2017Deutsche BankDowngradeBuy -> HoldN/AView Rating Details
9/8/2016CowenDowngradeOutperform -> Market Perform$65.00N/AView Rating Details
7/5/2016Raymond JamesDowngradeOutperform -> Market Perform$64.57 -> $64.57N/AView Rating Details
6/3/2016FBR & CoReiterated RatingOutperform$73.00N/AView Rating Details
5/6/2016Topeka Capital MarketsLower Price TargetBuy$65.00 -> $64.00N/AView Rating Details
(Data available from 4/24/2016 forward)


Cerner (NASDAQ:CERN) Earnings History and Estimates Chart

Earnings by Quarter for Cerner (NASDAQ:CERN)

Cerner (NASDAQ:CERN) Earnings Estimates

2018 EPS Consensus Estimate: $2.41
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.53$0.53$0.53
Q2 20182$0.57$0.60$0.59
Q3 20184$0.61$0.64$0.63
Q4 20184$0.61$0.70$0.66

Cerner (NASDAQ CERN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$0.59N/AView Earnings Details
2/6/2018Q4 2017$0.61$0.58$1.3255 billion$1.3140 billionViewListenView Earnings Details
10/26/2017Q3 2017$0.62$0.61$1.2949 billion$1.2760 billionViewN/AView Earnings Details
7/27/2017Q2 2017$0.57$0.56$1.3025 billion$1.2920 billionViewN/AView Earnings Details
4/27/2017Q1 17$0.53$0.59$1.2285 billion$1.26 billionViewN/AView Earnings Details
2/9/2017Q416$0.61$0.61$1.26 billion$1.26 billionViewListenView Earnings Details
11/1/2016Q316$0.56$0.55$1.24 billion$1.19 billionViewListenView Earnings Details
8/2/2016Q216$0.57$0.58$1.21 billion$1.22 billionViewListenView Earnings Details
5/5/2016Q1$0.53$0.53$1.17 billion$1.14 billionViewListenView Earnings Details
2/16/2016Q4$0.57$0.61$1.17 billion$1.18 billionViewListenView Earnings Details
11/3/2015Q315$0.54$0.54$1.17 billion$1.1280 billionViewListenView Earnings Details
8/4/2015Q215$0.52$0.52$1.20 billion$1.29 billionViewListenView Earnings Details
5/7/2015Q115$0.45$0.45$1.09 billion$996.10 millionViewListenView Earnings Details
2/10/2015Q414$0.47$0.47$904.60 million$926.00 millionViewListenView Earnings Details
10/23/2014Q314$0.42$0.42$855.60 million$840.00 millionViewListenView Earnings Details
7/24/2014Q214$0.40$0.40$813.77 million$851.80 millionViewListenView Earnings Details
4/24/2014Q114$0.37$0.37$784.72 million$784.80 millionViewListenView Earnings Details
2/4/2014Q413$0.39$0.39$794.22 million$793.20 millionViewListenView Earnings Details
10/24/2013Q313$0.35$0.35$757.20 million$727.80 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.34$0.34$725.71 million$707.60 millionViewListenView Earnings Details
4/25/2013Q1 2013$0.63$0.66$708.43 million$680.00 millionViewListenView Earnings Details
2/5/2013Q4 2012$0.64$0.67$696.52 million$710.40 millionViewListenView Earnings Details
10/25/2012$0.59$0.60ViewN/AView Earnings Details
7/26/2012$0.54$0.59ViewN/AView Earnings Details
4/26/2012$0.50$0.54ViewN/AView Earnings Details
2/7/2012$0.52$0.55ViewN/AView Earnings Details
10/27/2011$0.47$0.48ViewN/AView Earnings Details
7/28/2011$0.43$0.44ViewN/AView Earnings Details
4/28/2011$0.76$0.80ViewN/AView Earnings Details
2/8/2011$0.84$0.87ViewN/AView Earnings Details
10/28/2010Q3 2010$0.18$0.18ViewN/AView Earnings Details
7/28/2010Q2 2010$0.16$0.16ViewN/AView Earnings Details
4/28/2010Q1 2010$0.14$0.15ViewN/AView Earnings Details
2/9/2010Q4 2009$0.17$0.18ViewN/AView Earnings Details
10/28/2009Q3 2009$0.14$0.14ViewN/AView Earnings Details
7/29/2009Q2 2009$0.13$0.13ViewN/AView Earnings Details
4/28/2009Q1 2009$0.12$0.12ViewN/AView Earnings Details
2/10/2009Q4 2008$0.15$0.15ViewN/AView Earnings Details
10/21/2008Q3 2008$0.13$0.13ViewN/AView Earnings Details
7/22/2008Q2 2008$0.12$0.12ViewN/AView Earnings Details
4/22/2008Q1 2008$0.10$0.11ViewN/AView Earnings Details
1/31/2008Q4 2007$0.12$0.12ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Cerner (NASDAQ:CERN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Cerner (NASDAQ CERN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.71%
Institutional Ownership Percentage: 78.76%
Insider Trading History for Cerner (NASDAQ:CERN)
Insider Trading History for Cerner (NASDAQ:CERN)

Cerner (NASDAQ CERN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/8/2018Clifford W IlligVice ChairmanSell307,700$64.52$19,852,804.001,229,719View SEC Filing  
2/13/2018Jeffrey A. TownsendVPSell230,000$61.94$14,246,200.00View SEC Filing  
2/8/2018William D. ZollarsDirectorSell4,100$62.16$254,856.00View SEC Filing  
12/13/2017Michael R BattaglioliVPSell4,000$69.89$279,560.004,000View SEC Filing  
12/13/2017Zane M. BurkePresidentSell50,000$70.00$3,500,000.00View SEC Filing  
11/30/2017Marc G. NaughtonCFOSell60,000$70.64$4,238,400.00View SEC Filing  
11/20/2017Clifford W IlligChairmanSell530,000$65.54$34,736,200.001,229,719View SEC Filing  
11/16/2017Clifford W IlligCEOSell140,000$65.52$9,172,800.001,229,719View SEC Filing  
11/7/2017Clifford W IlligChairmanSell4,000$65.96$263,840.001,229,719View SEC Filing  
9/13/2017Michael NillCOOSell99,470$70.45$7,007,661.50View SEC Filing  
9/5/2017Zane M. BurkePresidentSell94,000$67.47$6,342,180.00View SEC Filing  
9/1/2017Randy D SimsSVPSell60,000$68.03$4,081,800.0060,890View SEC Filing  
8/11/2017Clifford W IlligChairmanSell118,113$62.03$7,326,549.391,229,719View SEC Filing  
6/9/2017Gerald E. Bisbee, Jr.DirectorSell6,200$67.97$421,414.00View SEC Filing  
6/7/2017Julie M. WilsonEVPSell60,000$68.15$4,089,000.00View SEC Filing  
6/6/2017Marc G. NaughtonCFOSell60,000$68.63$4,117,800.00View SEC Filing  
5/22/2017Linda M. DillmanDirectorSell4,600$64.69$297,574.00View SEC Filing  
5/12/2017Neal L PattersonChairmanSell43,000$64.33$2,766,190.00View SEC Filing  
5/11/2017Clifford W IlligVice ChairmanSell234,525$64.43$15,110,445.751,229,719View SEC Filing  
5/8/2017Neal L PattersonChairmanSell180,667$64.71$11,690,961.57View SEC Filing  
5/4/2017Denis A CorteseDirectorSell1,550$64.39$99,804.50View SEC Filing  
5/4/2017Michael NillCOOSell110,000$63.91$7,030,100.00View SEC Filing  
5/1/2017Michael R BattaglioliVPSell4,000$65.55$262,200.004,000View SEC Filing  
3/14/2017Neal L PattersonChairmanSell20,000$54.91$1,098,200.00View SEC Filing  
2/13/2017Jeffrey A. TownsendVPSell100,000$52.31$5,231,000.00View SEC Filing  
11/7/2016William D. ZollarsDirectorSell10,000$51.50$515,000.00View SEC Filing  
9/6/2016Linda M. DillmanDirectorSell6,000$64.68$388,080.00View SEC Filing  
8/18/2016Clifford W IlligVice ChairmanSell325,705$65.10$21,203,395.506,652,392View SEC Filing  
8/10/2016Zane M. BurkePresidentSell149,480$66.73$9,974,800.40View SEC Filing  
8/9/2016Neal L PattersonChairmanSell428,638$67.14$28,778,755.32View SEC Filing  
8/8/2016Julie M. WilsonEVPSell46,923$67.27$3,156,510.21View SEC Filing  
8/8/2016Michael NillCOOSell50,000$67.16$3,358,000.00View SEC Filing  
8/8/2016Michael R BattaglioliVPSell2,000$67.34$134,680.002,000View SEC Filing  
6/1/2016William D ZollarsDirectorSell9,000$55.72$501,480.0044,486View SEC Filing  
5/23/2016Linda M DillmanDirectorSell3,700$54.46$201,502.0034,243View SEC Filing  
5/12/2016Neal L PattersonCEOSell40,000$54.24$2,169,600.00View SEC Filing  
2/19/2016Jeffrey A. TownsendVPSell100,000$51.48$5,148,000.00View SEC Filing  
2/19/2016William D. ZollarsDirectorSell11,680$51.40$600,352.00View SEC Filing  
12/14/2015Julie M. WilsonEVPSell2,821$60.52$170,726.9232,895View SEC Filing  
12/10/2015Michael R. BattaglioliCAOSell2,000$60.06$120,120.00View SEC Filing  
6/3/2015Clifford W IlligVice ChairmanSell20,261$67.59$1,369,440.99View SEC Filing  
6/3/2015Neal L PattersonCEOSell252,340$67.37$17,000,145.80View SEC Filing  
5/26/2015Denis A CorteseDirectorSell4,000$67.52$270,080.00View SEC Filing  
5/20/2015Gerald E Bisbee JrDirectorSell6,400$68.40$437,760.00View SEC Filing  
5/19/2015Linda M DillmanDirectorSell5,900$68.63$404,917.00View SEC Filing  
5/12/2015William D ZollarsDirectorSell7,400$67.63$500,462.00View SEC Filing  
3/9/2015Michael NillCOOSell50,000$70.45$3,522,500.00View SEC Filing  
3/2/2015Zane M BurkePresidentSell50,000$71.85$3,592,500.00View SEC Filing  
2/27/2015Jeffrey A TownsendVPSell120,000$72.13$8,655,600.00View SEC Filing  
2/25/2015Neal L PattersonCEOSell54,000$73.00$3,942,000.00View SEC Filing  
2/19/2015Randy D SimsSVPSell28,874$71.11$2,053,230.14View SEC Filing  
2/18/2015Neal L PattersonCEOSell325,492$70.06$22,803,969.52View SEC Filing  
2/13/2015Marc G NaughtonCFOSell40,000$70.95$2,838,000.00View SEC Filing  
2/13/2015Michael R BattaglioliCAOSell2,000$70.92$141,840.00View SEC Filing  
2/13/2015Randy D SimsSVPSell31,126$71.06$2,211,813.56View SEC Filing  
12/1/2014Julie M WilsonEVPSell22,000$64.58$1,420,760.00View SEC Filing  
11/26/2014Clifford W IlligChairmanSell124,084$63.44$7,871,888.96View SEC Filing  
11/25/2014Clifford W IlligChairmanSell2,900$64.50$187,050.00View SEC Filing  
11/18/2014Clifford W IlligChairmanSell116,586$64.51$7,520,962.86View SEC Filing  
11/6/2014Randy D SimsSVPSell43,162$63.65$2,747,261.30View SEC Filing  
11/4/2014Randy D SimsSVPSell26,838$63.51$1,704,481.38View SEC Filing  
11/3/2014William D ZollarsDirectorSell7,900$63.30$500,070.00View SEC Filing  
10/28/2014Michael NillCOOSell50,000$62.72$3,136,000.00View SEC Filing  
9/8/2014Julie M WilsonEVPSell16,000$59.53$952,480.00View SEC Filing  
9/3/2014Michael R BattaglioliCAOSell2,000$59.21$118,420.00View SEC Filing  
8/13/2014Neal L PattersonCEOSell54,000$56.38$3,044,520.00View SEC Filing  
8/8/2014William D ZollarsDirectorSell9,200$55.20$507,840.00View SEC Filing  
5/30/2014Denis A CorteseDirectorSell4,000$54.42$217,680.00View SEC Filing  
3/11/2014Neal PattersonCEOSell231,000$60.31$13,931,610.00View SEC Filing  
2/14/2014Neal PattersonCEOSell15,000$59.90$898,500.00View SEC Filing  
2/13/2014Michael NillCOOSell50,000$57.94$2,897,000.0081,612View SEC Filing  
2/10/2014Michael BattaglioliCAOSell2,000$56.08$112,160.00View SEC Filing  
11/8/2013Marc NaughtonCFOSell40,000$56.57$2,262,800.0071,542View SEC Filing  
11/7/2013Neal PattersonCEOSell4,000$55.67$222,680.00View SEC Filing  
11/1/2013Zane M BurkePresidentSell39,000$55.98$2,183,220.00View SEC Filing  
10/30/2013Michael R BattaglioliCAOSell2,400$56.85$136,440.00View SEC Filing  
9/12/2013Julie WilsonEVPSell58,000$48.57$2,817,060.0010,522View SEC Filing  
9/12/2013Michael NillCOOSell48,320$48.77$2,356,566.4081,612View SEC Filing  
8/1/2013Marc G NaughtonCFOSell80,000$49.50$3,960,000.00View SEC Filing  
8/1/2013Neal L PattersonCEOSell1,000$49.59$49,590.00View SEC Filing  
6/12/2013Denis A CorteseDirectorSell2,000$98.00$196,000.00View SEC Filing  
5/23/2013William D ZollarsDirectorSell10,540$95.60$1,007,624.00View SEC Filing  
5/17/2013Neal L PattersonCEOSell30,000$97.05$2,911,500.00View SEC Filing  
5/15/2013Julie M WilsonEVPSell28,000$96.61$2,705,080.00View SEC Filing  
5/14/2013Neal L PattersonCEOSell15,000$95.38$1,430,700.00View SEC Filing  
5/9/2013Jeffrey A TownsendVPSell195,664$94.98$18,584,166.72View SEC Filing  
(Data available from 1/1/2013 forward)


Cerner (NASDAQ CERN) News Headlines

Can Higher System Sales Drive Cerners (CERN) Q1 Earnings?Can Higher System Sales Drive Cerner's (CERN) Q1 Earnings? - April 24 at 5:30 PM
Cerner touts DoD contract progress, but full rollout will wait until 2019Cerner touts DoD contract progress, but full rollout will wait until 2019 - April 24 at 5:30 PM
UPDATE: Citi Upgrades Cerner (CERN) to BuyUPDATE: Citi Upgrades Cerner (CERN) to Buy - April 23 at 8:20 AM
Cerner (CERN) Upgraded to Buy at CitigroupCerner (CERN) Upgraded to Buy at Citigroup - April 23 at 7:40 AM
Cerner (CERN) Lifted to Strong-Buy at BidaskClubCerner (CERN) Lifted to Strong-Buy at BidaskClub - April 20 at 12:41 PM
Epic Systems and MEDITECH Rise Atop Black Book 2018 Survey of Inpatient EHR Client Satisfaction Joining Cerner and CPSIEpic Systems and MEDITECH Rise Atop Black Book 2018 Survey of Inpatient EHR Client Satisfaction Joining Cerner and CPSI - April 20 at 8:10 AM
That complexity has a tendency to eat you alive: Technology companies face a massive challenge as they move into ...'That complexity has a tendency to eat you alive': Technology companies face a massive challenge as they move into ... - April 19 at 5:33 PM
The Menninger Clinic Selects Cerner Millennium Electronic Health RecordThe Menninger Clinic Selects Cerner Millennium Electronic Health Record - April 19 at 5:33 PM
With Cerner contract pending, VA CIO resignsWith Cerner contract pending, VA CIO resigns - April 19 at 5:33 PM
Here's Why You Should Hold on to Cerner (CERN) Stock for NowHere's Why You Should Hold on to Cerner (CERN) Stock for Now - April 18 at 5:40 PM
$1.34 Billion in Sales Expected for Cerner (CERN) This Quarter$1.34 Billion in Sales Expected for Cerner (CERN) This Quarter - April 17 at 5:01 AM
Cerner to Release First Quarter 2018 Earnings Results May 2Cerner to Release First Quarter 2018 Earnings Results May 2 - April 16 at 5:15 PM
Cerner (CERN) Rating Lowered to Hold at BidaskClubCerner (CERN) Rating Lowered to Hold at BidaskClub - April 16 at 12:05 PM
Factors of Influence in 2018, Key Indicators and Opportunity within Cerner, Extended Stay America, DENTSPLY ...Factors of Influence in 2018, Key Indicators and Opportunity within Cerner, Extended Stay America, DENTSPLY ... - April 16 at 8:23 AM
Cerner (CERN) Given Hold Rating at Stifel NicolausCerner (CERN) Given Hold Rating at Stifel Nicolaus - April 15 at 11:33 AM
$0.59 Earnings Per Share Expected for Cerner (CERN) This Quarter$0.59 Earnings Per Share Expected for Cerner (CERN) This Quarter - April 15 at 1:17 AM
Cerner (CERN) Downgraded to "Sell" at BidaskClubCerner (CERN) Downgraded to "Sell" at BidaskClub - April 14 at 6:22 PM
Cerner, AANAC Award Nursing Assistant of the Year ScholarshipCerner, AANAC Award Nursing Assistant of the Year Scholarship - April 13 at 5:26 PM
Munising Memorial Hospital Selects Cerner CommunityWorks Munising Memorial Hospital Selects Cerner CommunityWorks - April 12 at 5:30 PM
Munising Memorial Hospital Selects Cerner CommunityWorks℠Munising Memorial Hospital Selects Cerner CommunityWorks℠ - April 12 at 5:30 PM
Cerner (CERN) Stock Rating Upgraded by Morgan StanleyCerner (CERN) Stock Rating Upgraded by Morgan Stanley - April 11 at 12:42 AM
Rankin County Hospital District Launches Cerner Electronic Health RecordRankin County Hospital District Launches Cerner Electronic Health Record - April 9 at 5:15 PM
Cerner gives five-figure raises to its top execsCerner gives five-figure raises to its top execs - April 9 at 5:15 PM
Cerner (CERN) Given Consensus Rating of "Hold" by BrokeragesCerner (CERN) Given Consensus Rating of "Hold" by Brokerages - April 8 at 5:19 AM
Cerner's EHR to Aid Kern Medical's Population ManagementCerner's EHR to Aid Kern Medical's Population Management - April 6 at 5:36 PM
Kern Medical Selects Cerner Enterprisewide Health IT System and Population Health PlatformKern Medical Selects Cerner Enterprisewide Health IT System and Population Health Platform - April 5 at 5:13 PM
MedTech Takes to Big Data Analytics: 3 Stocks Catch EyeMedTech Takes to Big Data Analytics: 3 Stocks Catch Eye - April 5 at 10:20 AM
Monday Properties finds neighbor for Nestle at 1812 N. MooreMonday Properties finds neighbor for Nestle at 1812 N. Moore - April 4 at 4:08 PM
IRCCO Picks Cerners HealtheIntent For Patients of IllinoisIRCCO Picks Cerner's HealtheIntent For Patients of Illinois - April 4 at 11:44 AM
Cerners (CERN) "Buy" Rating Reiterated at Royal Bank of CanadaCerner's (CERN) "Buy" Rating Reiterated at Royal Bank of Canada - April 3 at 9:17 AM
What is Behind Cerner Corporation’s (NASDAQ:CERN) Superior ROE?What is Behind Cerner Corporation’s (NASDAQ:CERN) Superior ROE? - April 3 at 8:31 AM
Cerner (CERN) Lifted to Outperform at Robert W. BairdCerner (CERN) Lifted to Outperform at Robert W. Baird - April 2 at 9:12 PM
Cerner (CERN) Downgraded by Zacks Investment Research to "Sell"Cerner (CERN) Downgraded by Zacks Investment Research to "Sell" - April 2 at 8:08 PM
Illinois Rural Community Care Organization Selects Cerner HealtheIntent to Help Manage Medicare Claims for ACOIllinois Rural Community Care Organization Selects Cerner HealtheIntent to Help Manage Medicare Claims for ACO - April 2 at 5:21 PM
Cerner (CERN) Cut to "Outperform" at Royal Bank of CanadaCerner (CERN) Cut to "Outperform" at Royal Bank of Canada - April 2 at 8:39 AM
KeyCorp Reaffirms Buy Rating for Cerner (CERN)KeyCorp Reaffirms Buy Rating for Cerner (CERN) - April 2 at 7:17 AM
Wells Fargo Reiterates $75.00 Price Target for Cerner (CERN)Wells Fargo Reiterates $75.00 Price Target for Cerner (CERN) - April 1 at 10:21 AM
$1.34 Billion in Sales Expected for Cerner Co. (CERN) This Quarter$1.34 Billion in Sales Expected for Cerner Co. (CERN) This Quarter - March 31 at 4:36 AM
Cerner (CERN) Given Buy Rating at Robert W. BairdCerner (CERN) Given Buy Rating at Robert W. Baird - March 30 at 10:36 PM
More Than 20 Cerner Executives Earn Board Certification in Health Care ManagementMore Than 20 Cerner Executives Earn Board Certification in Health Care Management - March 30 at 5:25 PM
Capstone Awards 2018: Special Judges Recognition — Cerner Innovations CampusCapstone Awards 2018: Special Judges' Recognition — Cerner Innovations Campus - March 30 at 8:31 AM
Cerner (CERN) Lifted to Buy at Zacks Investment ResearchCerner (CERN) Lifted to Buy at Zacks Investment Research - March 29 at 9:36 PM
What Shulkins ouster might mean for Cerners multibillion-dollar contractWhat Shulkin's ouster might mean for Cerner's multibillion-dollar contract - March 29 at 5:24 PM
Cerner (CERN) Receives Buy Rating from William BlairCerner (CERN) Receives Buy Rating from William Blair - March 29 at 11:16 AM
Zacks: Analysts Anticipate Cerner Co. (CERN) Will Post Earnings of $0.59 Per ShareZacks: Analysts Anticipate Cerner Co. (CERN) Will Post Earnings of $0.59 Per Share - March 29 at 5:17 AM
SunTrust Banks Downgrades Cerner (CERN) to HoldSunTrust Banks Downgrades Cerner (CERN) to Hold - March 28 at 3:14 PM
Cerner (CERN) Downgraded to "Hold" at Zacks Investment ResearchCerner (CERN) Downgraded to "Hold" at Zacks Investment Research - March 28 at 2:06 PM
Cerner (CERN) Receives New Coverage from Analysts at Bank of AmericaCerner (CERN) Receives New Coverage from Analysts at Bank of America - March 24 at 9:28 PM
Head-To-Head Review: Cerner (CERN) vs. athenahealth (ATHN)Head-To-Head Review: Cerner (CERN) vs. athenahealth (ATHN) - March 18 at 5:18 PM
Argus Lowers Cerner (CERN) to HoldArgus Lowers Cerner (CERN) to Hold - March 18 at 11:25 AM

SEC Filings

Cerner (NASDAQ:CERN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Cerner (NASDAQ:CERN) Income Statement, Balance Sheet and Cash Flow Statement


Cerner (NASDAQ CERN) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.